New RA drug candidate CIGB-814 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug called CIGB-814 in 70 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. This is the first step before testing it in people with rheumatoid arthritis.
Phase: PHASE1 • Sponsor: Yi Fang • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC